The purchase brought Tianjin Pharmaceutical Holdings’ total stake in the company to 43.008% from 42.997% previously. Tianjin Pharmaceutical Holdings now owns a total of 331.2 million shares, of which 5.35 million are listed on the SGX.
Tianjin Pharmaceutical Holdings, the controlling shareholder of Mainboard-listed Tianjin Pharmaceutical Da Ren Tang Group, has acquired 82,200 shares on the Singapore Exchange Securities Trading Limited (SGX-ST) for US$242,952.79 ($309,560.72) or at an average price of US$2.96 per share on Feb 4.
The shares were acquired through Tianjin Pharmaceutical Holdings’ wholly-owned subsidiary, JinYao Global on Feb 4.
